Eden Review: The $99 GLP-1 That Bills $198 a Month

Twice what the headline says, and Eden tells you so in the footnote. Compounded semaglutide is $99 a month for the medication; compounded tirzepatide is $199. On top of either sits a required Eden Membership at $39 for the first month, auto-renewing at $99 a month. So semaglutide is $138 in month one and $198 in every month after; tirzepatide is $238 then $298. Read off eden.health/treatment/glp-1-treatments on August 7, 2026, and confirmed against the pricing code in Eden's own checkout.

Semaglutide: $138 for the first month plus eleven at $198 is $2,316. Tirzepatide: $238 plus eleven at $298 is $3,516. Neither figure moves with your dose, which is unusual — most sellers in this category re-price when you titrate up, so a year quoted at the starting dose understates what you will actually spend. Eden's does not.

No. Eden's footnote is unambiguous: "Medication is not available without a membership." The same footnote also says the membership "does not include or guarantee a prescription", so the two facts sit together — you must pay it to buy, and paying it does not entitle you to anything. What it does buy is unlimited 24/7 messaging with the care team, dose changes at no extra charge, and free expedited shipping. Whether that is worth $1,188 a year is a judgement; whether you can decline it is not.

No, and this is Eden's best feature. Its own benefits line reads "Same price at every dose. No long-term contracts." The claim survives inspection: the function that resolves price in Eden's checkout takes the compound and nothing else — semaglutide resolves to $99, tirzepatide to $199 — with no dose term anywhere in it. For a drug you are expected to titrate over months, that turns a quote into a plan.

Eden lists them, at cash prices that are hard to justify. On August 7, 2026 its page showed Ozempic, Zepbound and Mounjaro at $1,399 a month and Wegovy at $1,695, all before the $99 membership. For comparison, Eli Lilly and Novo Nordisk both sell the same branded products direct to self-pay patients for a fraction of that. If you have decided you want the branded drug, this is not the door to walk through.

Every state, yes. Eden does not publish a coverage page, so this comes from the state table inside its own sign-up app, read on August 7, 2026: fifty entries, one per state, every one flagged available, with no restricted or limited tier of the kind other telehealth funnels carry. Washington, D.C. is the gap — it does not appear in that table at all, so there is no route through the intake for a D.C. address.

Two things, and the second one is worth understanding whoever you buy from. On June 8, 2026 FDA wrote to Eden Health International Inc. about tryeden.com. The first violation was the private-label finding that runs through this whole enforcement wave: the vials pictured carry Eden's name, which represents Eden as the compounder, and Eden is not. The second has no parallel elsewhere. Eden's site said its products came from "FDA-licensed 503(a) outsourcing facilities", and FDA replied that no such designation exists — compounding pharmacies and outsourcing facilities are neither FDA-approved nor FDA-licensed, and registering under section 503B is not approval. Both are labelling findings under FDCA 502(a) and 502(bb). Nothing in the letter concerns sterility, potency or contamination.

Cancelling is easy and free. Eden's own FAQ: "You can easily cancel your treatment plan from within your online patient portal. There are no cancellation fees or long-term contracts." The catch is timing rather than money — cancelling in the portal does not stop an order that has already gone to the pharmacy, and Eden tells you to email support if an order is still pending. Since the membership renews monthly rather than in a block, the most you can be exposed to is one month you did not want.